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STUDY SYNOPSIS  
Traumatic anterior shoulder dislocation (TASD) is a common injury [1] within young (<40 years of 
age) active individuals [2] and induce a high risk for recurrent anterior shoulder dislocation to 
evolve due to post-traumatic pathophysiological changes in the shoulder joint [3]. Recurrent 
anterior shoulder dislocation may have negative consequences for shoulder function, with joint 
stability being further compromised after every dislocation. Thus, patients are often limited in 
sports-related and social activities affecting their shoulder-related Quality of Life (QoL) [4-7]. 
Standard care consists of orthopedic manually treated shoulder reduction at emergency 
departments, followed by shoulder immobilization and, if provided, some kind of physiotherapy 
[8]. However, there is no evidence-based exercise program to prescribe for patients with TASD [3] 
and studies investigating non-surgical treatment for this patient group is low [9].  
The current study will shed light on the effect of non-operative treatment for patients with trauma-
initiated primary and subsequent recurrent anterior shoulder dislocation and provide foundation for 
non-operative treatment guidelines. Additionally, this trial will support evidence-based shared 
decision-making processes between physicians and patients in clinical practice, when patients seek 
orthopedic and/or physiotherapy treatment for a primary or recurrent anteriorly dislocated shoulder.  
Ethical Trial registration: S-20140093 
Clinicaltrial.gov registration: (NCT02371928) 
STUDY OBJECTIVES AND OUTCOMES 
The primary outcome, the Western Ontario Shoulder Instability Index (WOSI) [10], was obtained 
for all participants at baseline, four, and eight weeks, besides at follow-up at three months (12 
weeks). The secondary outcomes were obtained from all participants at baseline and at follow-up 
after 3 months (12 weeks).  
This study tests the hypothesis that patients with TASD treated with shoulder neuromuscular 
exercises (intervention, SINEX group) will experience and report larger improvements in shoulder 
related QoL, pain and function, respectively, than those treated with instructions on self-managed 
shoulder exercise program (control, Standard Care group).  
 
The intervention (SINEX) group received: 12 weeks of individually physiotherapist-supervised 
exercise specifically targeting the rotator cuff and scapular muscles. Moreover, functional kinetic 
chain exercises are incorporated for progressing to more difficult levels, mimicking daily activities 
and improving the transferability of everyday activities. In total, seven exercises are included in the 
SINEX program and can be individually progressed from basic to elite level (A to G). Participants 
are instructed to perform each exercise at home as follows; exercises at basic levels (A to E) seven 
days a week and exercises at elite levels (F to G) three times a week. Participants are provided with 
online access to instructions and video recordings of each exercise and the accompanying levels of 
progression through the physiotherapy site www.digifys.com. Further, participants receive 
supervised physiotherapy sessions throughout the 12 weeks. The physiotherapists decide the 
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amount of supervision based upon movement control and capabilities of the individual patient. 
The control (Standard Care) group received: one introductory supervised physiotherapy session on 
how to perform the 12-week self-managed training-based shoulder exercise program consisting of 
strengthening exercises for the rotator cuff and scapular muscles. Exercises are performed three 
times weekly with 10x2 repetitions for each exercise. Also, patients are provided a leaflet 
containing photos and descriptions of each exercise. 
 
All methods are described in the protocol published by Eshoj et al. [11]. To meet the required 
sample size of patients with TASD, an adjusted power calculation was performed after publishing 
the protocol. 
PRIMARY OBJECTIVE AND OUTCOME  
The primary objective in this randomized controlled trial was to evaluate the efficacy and safety of 
a 12-week physiotherapist-supervised neuromuscular shoulder exercise (SINEX) program in 
comparison with 12-weeks of self-managed shoulder exercise program (standard care) in patients 
with TASD as measured by the primary outcome being the total score of (WOSI) questionnaire 
[10].  
The primary endpoint was chosen based upon the fact that the primary effect measure is a patient 
reported shoulder-related QoL outcome and not, as in previous trials including patients with 
primary TASD, whether the shoulder re-dislocates or not. Further, WOSI-total is recommended as 
primary outcome when evaluating patient reported treatment effects in patients with shoulder 
instability [12] and is translated, reliable and valid for use in Danish shoulder instability patients 
[13]. WOSI covers 21 items, ranging from 0-2100 with higher scores representing worse QOL [10] 
(Table 1). Each item is scored from 0-100 on a visual analogue scale. WOSI holds four 
subscales/domains; Physical symptoms (10 items), Sport/recreation/Work (4 items), Lifestyle (4 
items) and Emotions (4 items). Each of the WOSI subscales will be reported and analyzed as 
secondary outcomes. 
SECONDARY OBJECTIVES AND OUTCOMES  
The secondary objectives are to compare changes from baseline to the 12-weeks follow-up between 
the two treatment arms in a number of patient reported outcomes besides physical test measures. 
The secondary outcomes are to be used as support for the interpretation of the primary outcome. 
Also, these analyses can only be supportive, explanatory and/or hypothesis generating, which are 
why multiple comparisons are not deemed to be a problem. 
 
THE PATIENT REPORTED OUTCOME MEASURES 
1) The four subscales of the WOSI (with the level of no trouble equal to 0, accounting for all 
domains [10]): a. Physical symptoms (0-1000); b. Sport/recreation/work (0-400); c. Life-
style (0-400); d. Emotions (0-300) 
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2) The Tampa Scale of Kinesiophobia (TKS) questionnaire ranging from 17-68 with 68 
representing highest fear of movement and re-injury [14, 15] with scores equal to or above 
37 representing high fear of movement and re-injury [14]. 
  
3) Pain intensity at rest, within the latest 24 hours and seven days, respectively, using the 
Numeric Pain Rating Scale (NPRS) ranging from 0-10 score with 10 representing worst 
imaginable pain [16] 
 
4) Patient-rated important activity using the Pain Specific Function Scale (PSFS) scored at a 
NRS ranging from 0-10 with 10 indicating no problems in performing the activity [17].  
 
5) Health related QoL using the EQ-5D´s Visual Analogue Scale (EQ-VAS) ranging from 0 to 
100 with 0 representing lowest health-related quality of life.  
 
6) Cost-effective analysis using the total score of the EuroQol-5D-5L (EQ-5D) ranging from -
0.59 to 1 with -0.59 representing lowest scores [18].  
 
THE PHYSICAL OBJECTIVE TESTS  
1) Clinical evaluation of anterior shoulder instability using the clinical shoulder tests 
apprehension, relocation and surprise (positive, yes/no) [19], [20], [21]. 
 
2) The Constant-Murley Shoulder Score (CMS; 0-100 score, 100=best possible shoulder 
function [22] based on patient reported questions and objective physical test measures, 
consisting of shoulder range of movement (CMS-ROM) and isometric shoulder abduction 
strength (CMS-Strength). 
 
3) Shoulder proprioception using a repositioning test with patients blindfolded, asked to 
actively reproduce different shoulder angles within low ranges (equal to 60±10 degrees) of 
shoulder flexion and abduction. The test is conducted by using a laser beam attached at the 
elbow pointing towards pre-specified targets using a target scale [11, 23]. 
 
SELF-REPORTED HISTORICAL INFORMATION COLLECTED AT THE 3 
MONTHS FOLLOW UP  
1) Number of visits to the general practitioner or secondary healthcare system  
2) Number of new shoulder dislocation/subluxation events 
3) Number of days sick listed from work and sport attributed to the actual shoulder injury 
4) Number of referrals to or completed shoulder surgical procedures attributed to the actual 
shoulder injury 
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5) Global Perceived Effect (GPE) measures; evaluated using the question “Compared to when 
this treatment first started, how would you describe your current shoulder problem?’’ (7 
response categories ranging from very much worse to very much better) 
6) “If you had the choice, would you then consider having stabilizing shoulder surgery 
performed?” (Yes/no?) 
 
For further information on self-reported historical information, please see Table 4. 
 
DESCRIPTIVE OUTCOMES AND ADHERENCE 
Baseline descriptive outcomes are to be published separately by Eshoj and colleagues (proposed 
title: “Patients with primary or recurrent traumatic anterior shoulder dislocation have equally poor 
self-reported and measured shoulder function - a cross-sectional study”) and are distributed by 
number of dislocations (primary versus recurrent up to five dislocations). 
 
Adherence to the (intervention) SINEX program: registered by the treating physiotherapists as 
number of supervised sessions attended by the patient. For treatment-related variables adherence is 
classified in accordance with the following criteria: 
• Satisfactory (as defined per protocol) adherence for the patients is 50% participation (at least 
seven supervised sessions out of 14 possible sessions), besides  
• Completion of at least two thirds (66%) of the scheduled home-based exercises registered by 
use of training diary.  
 
Adherence to the (control) Standard Care program: Completion of at least two thirds (66%) of the 
scheduled home-based exercises registered by use of training diary.  
PRIMARY ENDPOINT 
This study was designed as an exploratory superiority trial with two groups (SINEX and Standard 
Care) using the patient reported WOSI questionnaire as primary outcome. It was expected that the 
group allocated to SINEX improved 250 points more than the group allocated to standard care 
based on the primary outcome WOSI-total at the end point after 3 months. Thus, the primary 
endpoint is based upon the between group difference in change in the total WOSI score.  
SECONDARY ENDPOINTS 
The secondary endpoints will be analyzed for between group differences in change from baseline to 
the 3 months follow up. For sensitivity and exploratory purposes a per-protocol analysis, including 
those with good compliance, as defined above, will be performed.  
STUDY DESIGN 
This trial was a multi-center randomized (1:1), assessor-blinded, controlled clinical superiority trial 
with a paralleled group design investigating the efficacy and safety of SINEX versus standard care 
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for patients with TASD (see flowchart, Figure 1). Patient recruitment was conducted from three 
orthopedic shoulder units in The Region of Southern and Northern Denmark. Eligibility criteria 
were men and women aged 18-39 years with trauma initiated primary and subsequent recurrent 
anterior shoulder dislocation. All patients should comply with the following inclusion criteria: 
minimum one radiologic verified anterior shoulder dislocation, in addition to self-reported shoulder 
trouble within the latest week at the time of assessment for trial inclusion, e.g. reduced ability to 
perform specific shoulder movements during sports/leisure activity and/or work. Exclusion criteria 
were the following: humeral fracture and/or bony Bankart warranted for shoulder surgery, prior 
surgery in the affected shoulder joint, more than five anterior shoulder dislocations (verified by 
patient register or subjective evaluation), suspected competing diagnosis (e.g. rheumatoid arthritis, 
cancer, neurological disorders, fibromyalgia, schizophrenia, suicidal threatened, borderline 
personality disorder or obsessive compulsive disorder), sensory and motor deficits in neck and 
shoulder, pregnancy, inadequacy to write and speak Danish, besides not willing or able to attend 12 
weeks of a physical therapist-supervised neuromuscular shoulder exercise program.  
SAMPLE SIZE 
With a mean baseline WOSI-total score expected to be 1100 points (range 0-2100, with 2100 as 
worst possible score) and a common standard deviation assumed to be 320 [24], a sample size of 36 
participants per group was required to detect a statistical significant difference (significance level of 
0.05, 90% power). To account for possible barriers, non-compliant patients and participants’ lost-
to-follow-up, a total sample size of 80 participants (40:40) was targeted. 	
DEVIATION FROM TRIAL REGISTRATION  
According to trial registration at Clinicaltrials.gov (NCT02371928) a number of changes have been 
made. Due to difficulties with inclusion of patients it was decided by March 9th, 2016 to remove 
the inclusion criteria; Minimum two positive tests out of three clinical tests for anterior shoulder 
instability (apprehension, relocation and/or surprise).  
Further, due to poor validity of the prone lying shoulder sensorimotor control measurements [25] 
this outcome was omitted from the current trial. Finally, when registering the trial, a power of 90% 
was targeted. This was to allow for difficulties in recruitment and to take dropouts or non-compliant 
participants into consideration. However, a priori, it was decided to close the recruitment of 
participants on March 31th, 2017 after a recruitment period of 24 months [11]. Unfortunately, only 
56 patients were included at this time point. Though, despite not achieving the requested sample 
size of 80 patients, the results for the 56 patients included are reported since the outcome of this 
trial is of extreme importance since this is the first trial to compare the effect of two conservative 
treatment strategies for patients with anterior shoulder dislocation as is initiated by trauma.  
RANDOMIZATION, ALLOCATION AND BLINDING PROCEDURES  
Following baseline assessment patients were randomly assigned to either of the two exercise groups 
(SINEX vs. Standard Care). An independent biostatistician, with no involvement in the clinical care 
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of the patients, prepared a computer generated list of random numbers (1:1), packed at each trial 
site into sequentially numbered, opaque, concealed envelopes, stating which group every single 
individual was allocated to. A stratification technique was used based on injury status: (i) primary 
(first time) or (ii) recurrent (second–fifth) anterior shoulder dislocation. After randomization a 
research secretary, not involved in the outcome assessments, forwarded group assignments to a 
treating physiotherapist who contacted patients for scheduling an appointment for the first exercise 
instruction. Outcome assessors performing all outcome measurement were kept blinded according 
to treatment allocation and were also not involved in the treatment of patients.  
Blinding of treatment allocation for patient and physiotherapists were not possible due to the 
design. To retain the blinding of the outcome assessors, patients were encouraged not to reveal their 
treatment assignment, at the 3-month follow-up.  
STATISTICAL ANALYSIS  
The statistical analysis plan will be performed blinded according to group allocation and results will 
be interpreted in an author consensus statement prior to disclosing/revealing group allocation on the 
basis of a blinded review of the data from the primary endpoint (changes from treatment A 
compared to changes from treatment B), assuming that treatment A is the active treatment (SINEX), 
and the other assuming that treatment B is the active treatment (SINEX). Not until a signed consent 
from all of the authors of this trial (identical to the authors of this SAP) has been obtained, agreeing 
on one interpretation of the results only, the randomization code will be broken. This is done to 
reduce bias in the interpretation of the current findings.  
All analyses will follow the intention-to-treat principle; i.e. all randomized participants in the trial 
will be included in the analysis according to the group to which they were originally allocated, 
regardless of dropout/departures from allocated treatment. For the primary analysis, missing values, 
due to patient’s absence from follow-up or withdrawal from the study will be replaced using a non-
responder imputation, in which the baseline value is carried forward [26]. The rationale behind this 
type of analysis builds on the assumption that patients absent from follow up returns to scores 
obtained at baseline [27]. 
 
An analysis of covariance (ANCOVA) model will be used to analyze mean changes in continuous 
endpoints. The model will include test for interaction between treatment (SINEX/Standard Care) 
and Time (baseline/follow up), as well as treatment (SINEX/Standard Care), study center (Aalborg, 
Esbjerg Odense), injury status (primary or recurrent shoulder dislocation) and gender as fixed 
effects, with the baseline value of the relevant variable as covariates. Categorical outcomes for 
dichotomous endpoints will be analyzed with the use of logistic regression with the same covariates 
as the respective ANCOVA. 
For the longitudinal part of the trial a linear mixed effect ANCOVA model with repeated measures 
of the WOSI (4, 8 and 12 weeks) will be performed to test the difference over time between the 
SINEX and Standard Care group with interaction: treatment (SINEX/Standard Care) and Time (4, 
8, 12 weeks), with the same fixed effects and covariates as the respective ANCOVA. For these 
analyses the ‘data as observed’ will be applied (i.e. no imputation for missing data).  
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Overall, results will be expressed as the difference between groups with 95% confidence intervals 
and the associated p-values. Based on the principles related to superiority designs (in potential favor 
of SINEX), we prespecify that a 95% CI excluding differences between groups of greater than 200 
WOSI-total units would be interpreted as indicating the absence of a clinically meaningful 
difference [28]. Sensitivity analysis for difference between missing and completed data will be 
performed. Per protocol analyses will be performed between those who were exercise compliant in 
both groups.   
Statistical analyses will be performed with the Statistical Package form Social Sciences (SPSS), 
version 24.0. 
DISCONTINUED THE INTERVENTION 
Withdrawals and the reason for their withdrawal (if identified) were registered by the database 
manager and primary investigator (HE). Dropouts are defined as those who were not assessed at 3 
month follow up. All dropout patients are included in the ITT analysis with the baseline 
observations carried forward procedure.  
IMPLEMENTATION OF ANALYSIS PLAN  
A statistical analyst will perform the analysis of the primary outcome with no involvement from any 
of the study investigators.  
The implementation of the SAP for the SINEX study will follow the procedure below: 
1. A database model will be lined up in collaboration between the statistical advisor (RC) and 
principal investigator (HE). 
2. The database manager (AMR) will code each treatment arm into ‘group treatment A’ and 
‘group treatment B’, thus leaving all others blinded to treatment allocation during analysis. 
3. Blinded data will be delivered to the statistician (EB) according to the data base model.  
4. Primary analyses will be conducted blinded from allocation to any of the two treatment 
arms.  
5. Results will be presented to the primary investigator (HE) and co-authors of the manuscript.  
The authors will then agree upon two possible interpretations based on the analysis of the primary 
outcome data: one assuming that group A will be the active group, and the other assuming that B 
will be the active group. Therefore, a blinded interpretation of the primary endpoint results will be 
conducted before breaking the allocation. Thereafter, a consensus between all investigators will be 
reached regarding clinical interpretation of the results. Furthermore, all members of the author 
group will approve and sign the interpretations before any publication procedures are initiated [29]. 
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TABLE AND FIGURE LEGENDS  
 
Figure 1: Flow of participants throughout the study  
 
Table 1: Baseline demographic and historical information for patients with trauma initiated primary and subsequent 
recurrent anterior shoulder dislocation allocated to the SINEX vs. Standard care groups. Estimates are reported for each 
group and the total with Mean ± SD, n (%).  
 
Figure 2: Western Ontario Shoulder Instability (WOSI) total score at baseline, week 4, 8 and 12 for the SINEX vs. 
Standard Care Groups among patients with trauma initiated primary and recurrent anterior shoulder dislocation. Data 
are derived from repeated-measures Linear Mixed model and adjusted for baseline WOSI-total scores. The graph 
illustrates the results from the Intention-To-Treat population. Data points represent least squares means and error bars 
indicate 95% CIs. 
 
Table 2: Primary and secondary outcomes from baseline to 12-week follow-up for SINEX vs. Standard care groups 
among patients with trauma initiated primary and subsequent recurrent anterior shoulder dislocation, Intention-to-treat 
population. 
 
Table 3. Adverse Events from baseline to 12-week follow-up for SINEX vs. Standard care groups among patients with 
trauma initiated primary and subsequent recurrent anterior shoulder dislocation. 
 
Table 4. 12-week follow-up self-reported historical information for SINEX vs. Standard Care groups among patients 
with trauma initiated primary and subsequent recurrent anterior shoulder dislocation. 
Statistical Analysis Plan  The SINEX study 
	 11 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excluded (n)  
-Not meeting inclusion criteria (n) 
-Declined to participate (n) 
-Other reasons (n) 
Enrollment 
Assessed for eligibility (n=?) 
Allocated to standard care (n=) 
• Received allocated 
intervention (n=?) 
• Did not receive allocated 
intervention (n=?) 
o Reason  
 
 
Lost to follow-up (n)  
Discontinued intervention due to: 
- Surgery (n)  
- Other reasons (n) 
Randomized (n=) 
Centre 1 
Centre 2 
Centre 3 
Lost to follow-up (n)  
Discontinued intervention due to: 
- Surgery (n)  
- Other reasons (n) 
12-weeks follow-up 
 
Analysed (n=)  
- Excluded from analysis (n=)  
Analysed (n=)  
- Excluded from analysis (n=)  
Analysed (n=)  
- Excluded from analysis (n=)  
Analysed (n=)  
- Excluded from analysis (n=)  
As observed analysis	
Analysed (n=)  
- Excluded from analysis (n=)  
Analysed (n=)  
- Excluded from analysis (n=)  
Per protocol Analysis 
	
ITT Analysis 
	
Allocated to standard care (n=) 
• Received allocated 
intervention (n=?) 
• Did not receive allocated 
intervention (n=?) 
o Reason  
 
 
Allocation 
Figure 1  
Flowchart of the SINEX study 
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Table	1.	Baseline demographic and historical information for patients with trauma initiated 
primary and recurrent anterior shoulder dislocation allocated to the SINEX vs. Standard care 
groups. Estimates are reported for each group and the total with Mean ± Standard Deviation (SD), 
n (%). 
 
Variables  SINEX Group 
(n=..)  
Standard Care Group 
(n=..) 
Gender (male (%))   
Age (yrs) Mean (SD)   
Weight (kg) Mean (SD)   
Height (cm) Mean (SD)   
Educational level (n (%)) 
   Academic 
   White collar 
   Blue collar 
   Uneducated 
 
 
 
Employment status (n (%)) 
   Full-time 
   Part-time 
   Student    
   Un-employed/retired 
   Sick-leave 
 
 
 
Dominant arm (right (%))   
Injured shoulder (right (%))   
Injury mechanism (n (%)) 
   Fall on the arm 
   Pull in the arm 
   External force to the shoulder 
   Other 
 
 
 
Number of orthopedic treated shoulder 
reductions (n (%)) 
   Unknown 
   1 
   2 
   3 
   4 
   5 
 
 
 
Have you previously received any shoulder 
treatment? (n (%)) 
   No  
   Yes 
       Active PT exercise treatment 
       Passive treatment  
       Chiropractic  
       Analgesic medication (medically 
prescribed)  
 
 
 
Physically active? (n (%)) 
   No  
   Yes   
        ≥4 hours/week 
 
 
 
Primary outcome   
WOSI-total (0-2100)   
Secondary outcomes   
WOSI domains 
-Physical symptoms (0-1000) 
-Sport function  (0-400)  
-Lifestyle (0-400) 
-Emotions (0-300) 
  
TSK (17-68) 
≥37 (high re-injury fear), yes (%) 
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NPRS (latest 24 hours) (0-10)   
NPRS (latest 7 days) (0-10)   
EQ VAS (0-100)   
EQ-5D (-0.59 – +1)   
PSFS (0-10)   
GJH (0-9, positive ≥4, yes (%))   
Clinical tests (positive, yes, (%)):  
-Apprehension 
-Relocation 
-Surprise 
  
Total CMS (combined score, 0-100)   
CMS-ROM (combined score, 0-40)   
CMS-strength (kg) 
-Injured shoulder 
-Non-injured shoulder 
  
Shoulder JPSa (cm, AE) 
-Flexion (60 +/-10) 
-Abduction (60 +/-10) 
  
Abbreviations: WOSI Western Ontario Shoulder Instability Index; TSK Tampa Scale of 
Kinesiophobia; NPRS Numeric Pain Rating Scale; EQ VAS Euroqol Visual Analogue Scale; EQ-
5D Cost-effectiveness, total score of EuroQol-5D-5L; GJH Generalized Joint Hypermobility; 
PSFS Patients Specific Function Scale; CMS Constant Murley shoulder Score; CMS-ROM Range 
of Motion; JPS Joint Position Sense; cm centimeter; AE absolute error. Missing data = 
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Figure 2: Western Ontario Shoulder Instability (WOSI) total score at baseline, week 4, 8 and 12 for the SINEX vs. 
Standard Care Groups among patients with trauma initiated primary and recurrent anterior shoulder dislocation. Data 
are derived from repeated-measures Linear Mixed model and adjusted for baseline WOSI-total scores. The graph 
illustrates the results from the Intention-To-Treat population. Data points represent least squares means and error bars 
indicate 95% CIs. 																																				
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Table 2: Primary and secondary outcomes from baseline to 12 weeks follow-up for SINEX vs. Standard care groups 
among patients with trauma initiated primary and recurrent anterior shoulder dislocation, Intention-to-treat 
population 
 
 SINEX group (n=) Standard Care group (n=) Between-Group difference 
(95% CI) 
 
 Change (95% CI) Change (95% CI) P Value 
Primary outcome       
WOSI-total (0-2100)       
Secondary outcomes       
WOSI domains 
-Physical symptoms (0-1000) 
-Sport function  (0-400)  
-Lifestyle (0-400) 
-Emotions (0-300) 
      
TSK (17-68) 
≥37 (high re-injury fear), yes 
(%) 
      
NPRS (latest 24 hours) (0-10)       
NPRS (latest 7 days) (0-10)       
EQ VAS (0-100)       
EQ-5D (-0.59 – +1)       
PSFS (0-10)       
Clinical tests (positive, yes, 
(%)) 
-Apprehension  
-Relocation  
-Surprise 
      
Total CMS (combined score, 
0-100) 
      
CMS-ROM (combined score, 
0-40) 
      
CMS-strength (kg) 
-Injured shoulder 
-Non-injured shoulder 
      
Shoulder JPSa (cm, AE) 
-Flexion (60 +/- 10) 
-Abduction 
      
Abbreviations: WOSI Western Ontario Shoulder Instability Index; TSK Tampa Scale of Kinesiophobia; NPRS 
Numeric Pain Rating Scale; EQ VAS Euroqol Visual Analogue Scale; EQ-5D Cost-effectiveness, total score of 
EuroQol-5D-5L; PSFS Patients Specific Function Scale; CMS Constant Murley shoulder Score; CMS-ROM Range 
of Motion; JPS Joint Position Sense; cm centimeter; AE absolute error.  
Missing data =. 
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Table 3. Adverse Events (specific, serious, withdrawals due to adverse events, and deaths), as well as Between-
Group Risk Difference with 95% CI, from baseline to 12-week follow-up for SINEX vs. Standard Care groups 
among patients with trauma initiated primary and recurrent anterior shoulder dislocation. 
 
Adverse events SINEX group 
(n=) 
Standard Care group 
(n=) 
Between-Group Risk 
Difference with 95%CI 
-No. of shoulder related adverse events due the exercise 
program (n, (%)) 
-Pain 
-Soreness 
-Muscle fatigue 
-Other 
   
-No. of contacts to general practitioner due to shoulder 
related adverse events (n, (%)) 
   
-No. of contacts to orthopedic surgeon due to shoulder 
related adverse events (n, (%)) 
   
-Adverse events to other body parts due to the current 
exercise program (n, (%)) 
-No 
-Yes 
   
-Adverse events related to other body parts that lead to: 
-Orthopedic consultation (n, (%)) 
-General practitioner consultation (n, (%)) 
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Table 4. 12-week follow-up self-reported historical information for SINEX vs. Standard 
Care groups among patients with trauma initiated primary and subsequent recurrent anterior 
shoulder dislocation. 
 SINEX group 
(n=) 
Standard Care group 
(n=) 
P value 
Currently employed/under education (n (%)) 
-Yes 
-Yes, however, on sick-leave due to the current 
shoulder injury 
-No, due to the current shoulder injury 
-No, for other reasons than the current shoulder 
injury 
No. of days away from work/education due to the 
actual shoulder injury (n, (%)) 
-None 
-1-9 days 
-10-24 days 
-25-99 days 
   
No. of patients referred to or having completed 
shoulder stabilizing surgery (n, (%)) 
   
Experience of recurrent anterior shoulder 
dislocation (n, (%)) 
-no 
-yes 
   
-Experience of recurrent anterior shoulder 
instability (shoulder subluxation) (1-4)a 
   
No. of patients that went to/received other 
treatment than provided in the current study (n, 
(%)) 
-None 
-Physiotherapy  
-Corticosteroid injection  
-Massage  
-Acupuncture  
-Zone therapy  
-Other  
   
Use of painkillers (>3 days/week) due to the actual 
shoulder injury (n, (%)) 
-No 
-1-4/day  
-5-8/day 
-9-12/day 
->12/day 
   
No. of days sick listed from sport 
attributed to the actual shoulder injury (n, (%)) 
-None 
-1-9 days 
-10-24 days 
-25-99 days 
   
No. of days sick listed from work/education 
attributed to the actual shoulder injury (n, (%)) 
-None 
-1-9 days 
-10-24 days 
-25-99 days 
   
To what extent has your shoulder affected the 
quality of your duties at work/education within 
the last four weeks? (1-4)a, Mean (SD) 
   
To what extent has your shoulder affected the 
amount of duties solved at work/education within 
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the last four weeks? (1-4)a, Mean (SD) 
Returned to pre-injury level of sport (RTS) (1-4)a, 
Mean (SD) 
   
Thinking of your overall shoulder function, do 
you then consider your actual shoulder condition 
as satisfying (1-4)a, Mean (SD) 
   
Thinking of your overall shoulder function, do 
you then consider the current 12-week treatment 
to have failed (1-4)a, Mean (SD) 
   
GPE (-3 to +3) Mean (SD) 
-Compared to when this treatment first started, how 
would you describe your:  
-Actual shoulder function 
-Capability to perform activities of daily living  
-Capability to perform sport/leisure activities 
-Shoulder-related Quality of life 
   
Thinking of your current shoulder function, do 
you then consider having shoulder surgery 
performed? n, ( %)) 
-No 
-Yes 
   
No. of patients that complied with exercise 
protocol? (n, (%)) 
   
  a1 being “largely”, 4 being “not at all”); GPE Global Perceived Effect 
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